Trans-cranial Direct Current Stimulation on Alcohol Craving
Exploring the Effect of Trans-cranial Direct Current Stimulation on Craving and Serum BDNF of Patients With Alcohol Dependence
1 other identifier
interventional
60
1 country
1
Brief Summary
The goal of thisclinical trial is to investigate the efficacy of trans cranial direct current stimulation (tDCS) for alcohol craving in individuals with alcohol dependence. The main question it aims to answer is whether 10 sessions of tDCS can reduce craving for alcohol. Participants will be randomized into active group and sham group. Researchers will compare the severity of craving in these groups.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 17, 2023
CompletedFirst Submitted
Initial submission to the registry
April 18, 2023
CompletedFirst Posted
Study publicly available on registry
May 11, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 1, 2026
May 11, 2023
May 1, 2022
3.1 years
April 18, 2023
May 2, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in alcohol craving
Measured by visual analog scale, from 0-10
Before intervention (week 0) and after intervention (week 2)
Secondary Outcomes (1)
Change in brain-derived neurotrophic factor (BDNF)
Before intervention (week 0) and after intervention (week 2)
Study Arms (2)
Active tDCS
EXPERIMENTALThe intervention consisted of 10 daily 20-min sessions of bilateral prefrontal tDCS (anodal-right/cathodal-left, 2mA; 1 × 1 Mini-CT)
Sham tDCS
SHAM COMPARATORThe sham group consisted of 10 daily 20-min sessions of sham stimulation
Interventions
The intervention consisted of 20 daily 20-min sessions of bilateral prefrontal tDCS
The sham group consisted of 10 daily 20-min sessions of sham stimulation
Eligibility Criteria
You may qualify if:
- Be between 20-65 years of age
- have sufficient cognitive function to understand the study and complete the informed consent process
- Be diagnosed with alcohol dependence as defined by DSM-IV through a structured interview (Mini-International Neuropsychiatric Interview, M.I.N.I.)
You may not qualify if:
- Intellectual disabilities
- bipolar disorder
- Psychosis (schizophrenia)
- Major physical illness (brain hemorrhage, brain tumor, myocardial infarction, epilepsy or history of seizures)
- intracorporeal electronic or metal implants (e.g., cardiac pacemaker)
- Pregnant or breastfeeding women
- Allergy to headgear and electrode materials
- Trauma or infection to the head
- Intracranial space occupied lesion (such as brain tumor, AVM, etc.) or patients who have undergone brain surgery, meningitis and encephalitis
- Patients who are expected to undergo brain and major surgery during the trial period
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Taipei City Hospital
Taipei, Taipei CITY, 105, Taiwan
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 18, 2023
First Posted
May 11, 2023
Study Start
April 17, 2023
Primary Completion (Estimated)
June 1, 2026
Study Completion (Estimated)
June 1, 2026
Last Updated
May 11, 2023
Record last verified: 2022-05
Data Sharing
- IPD Sharing
- Will not share